Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab

Highlights • Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events.